LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

LLY

704.71

+0.12%↑

JNJ

178.66

+0.51%↑

ABBV

208.68

+1.3%↑

UNH

299.83

-1.31%↓

AZN

80.53

+1.23%↑

Search

Avalo Therapeutics

Gesloten

9.21 6.11

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

8.25

Max

9.21

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+262.81% upside

Avalo Therapeutics Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

20 aug 2025, 23:09 UTC

Winsten

Brambles Lifts Fiscal Year Profit 10%, Launches Fresh US$400 Million Buyback -- Update

20 aug 2025, 22:53 UTC

Winsten

AIA Posts Record New Business in 1st Half, Boosts Dividend

20 aug 2025, 22:45 UTC

Winsten

Brambles Lifts Fiscal Year Profit 10%, Launches Fresh US$400 Million Buyback

20 aug 2025, 22:32 UTC

Winsten

Goodman Targets 9% Earnings Growth in Fiscal Year 2026

20 aug 2025, 23:52 UTC

Marktinformatie

Global Equities Roundup: Market Talk

20 aug 2025, 23:52 UTC

Marktinformatie

Goodman Likely Conservative Again With Earnings Outlook -- Market Talk

20 aug 2025, 23:40 UTC

Marktinformatie

Nikkei May Decline After U.S. Tech Stocks Drop -- Market Talk

20 aug 2025, 22:54 UTC

Winsten

Brambles Lifts FY Profit 10%, Launches Fresh US$400M Buyback -- Update

20 aug 2025, 22:48 UTC

Acquisities, Fusies, Overnames

Doosan: Asset Sales Aimed at Securing Capital to Invest in Core Businesses

20 aug 2025, 22:47 UTC

Acquisities, Fusies, Overnames

Doosan: HD Korea Shipbuilding & Offshore Engineering to Buy Full Stake in Doosan Vina for $210M

20 aug 2025, 22:38 UTC

Winsten

AIA Posts Record New Business in 1H, Boosts Dividend

20 aug 2025, 22:30 UTC

Winsten

Brambles Lifts FY Profit 10%, Launches Fresh US$400M Buyback

20 aug 2025, 22:28 UTC

Winsten

Brambles: More Manufacturers Are Switching to Pooled Pallets>BXB.AU

20 aug 2025, 22:27 UTC

Winsten

Brambles: Tariff-Related Concerns Hit 2H Volume Growth>BXB.AU

20 aug 2025, 22:27 UTC

Winsten

Brambles: Growth With New Customers More Than Offset Volume Headwinds>BXB.AU

20 aug 2025, 22:24 UTC

Winsten

AIA Group Recommends Interim Dividend of 49.00 Hong Kong Cents/Share >1299.HK

20 aug 2025, 22:24 UTC

Winsten

AIA Group 1H Value of New Business Margin Was 57.7%, Up 3.4 Ppt on Year >1299.HK

20 aug 2025, 22:22 UTC

Winsten

AIA Group 1H Value of New Business $2.84B Vs. $2.46B >1299.HK

20 aug 2025, 22:17 UTC

Winsten

Goodman Targets 9% Earnings Growth in FY 2026

20 aug 2025, 22:16 UTC

Winsten

Brambles Completed $403M of Buybacks in FY 2025>BXB.AU

20 aug 2025, 22:16 UTC

Winsten

Brambles Announces New $400M on-Market Share Buyback>BXB.AU

20 aug 2025, 22:15 UTC

Winsten

Brambles: FY 2026 Guidance Excludes Currency Moves>BXB.AU

20 aug 2025, 22:14 UTC

Winsten

Brambles Expects FY 2026 Free Cash Flow Before Dividends of $850M-$950M>BXB.AU

20 aug 2025, 22:14 UTC

Winsten

Brambles Expects FY 2026 Underlying Profit Growth of 8-11%>BXB.AU

20 aug 2025, 22:14 UTC

Winsten

Brambles Expects FY 2026 Revenue Growth of 3-5%>BXB.AU

20 aug 2025, 22:13 UTC

Winsten

Brambles FY Post-Tax Operating Profit $864.2M, Up 13% Ex-Currency Moves>BXB.AU

20 aug 2025, 22:13 UTC

Winsten

Brambles FY Free Cash Flow Before Dividends $1.09B Vs. $883M>BXB.AU

20 aug 2025, 22:12 UTC

Winsten

Goodman FY 2025 Operating EPS Up 9.8%

20 aug 2025, 22:12 UTC

Winsten

St Barbara: FY Realized Gold Price from Continued Operations A$4,428/oz

20 aug 2025, 22:12 UTC

Winsten

Goodman Expects FY 2026 Operating EPS Growth of 9%

Peer Vergelijking

Prijswijziging

Avalo Therapeutics Prognose

Koersdoel

By TipRanks

262.81% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 32.29 USD  262.81%

Hoogste 48 USD

Laagste 15 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Avalo Therapeutics - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Financieel

$